Galectin Therapeutics
GALT
$3.23
Share price
2.87%
Change (1 day)
93.41%
Change (1 year)
Categories
Galectin Therapeutics (GALT) - Cash on Hand
Cash on Hand as of December 2023 : $25.66 M
According to Galectin Therapeutics's latest financial reports the company has $25.66 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Galectin Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $18.59 M | -53.11% |
| 2021-12-31 | $39.64 M | 46.08% |
| 2020-12-31 | $27.14 M | -42.83% |
| 2019-12-31 | $47.48 M | 475.31% |
| 2018-12-31 | $8.25 M | 170.32% |
| 2017-12-31 | $3.05 M | -80.13% |
| 2016-12-31 | $15.36 M | -40.56% |
| 2015-12-31 | $25.84 M | -11.27% |
| 2014-12-31 | $29.12 M | 177.7% |
| 2013-12-31 | $10.48 M | 12.01% |
| 2012-12-31 | $9.36 M | 46.38% |
| 2011-12-31 | $6.39 M | 8.59% |
| 2010-12-31 | $5.89 M | 2247.01% |
| 2009-12-31 | $0.25 M | -21.07% |
| 2008-12-31 | $0.31 M | -75.89% |
| 2007-12-31 | $1.31 M | -77.15% |
| 2006-12-31 | $5.77 M | 29.27% |
| 2005-12-31 | $4.46 M | -58.28% |
| 2004-12-31 | $10.7 M | 40.69% |
| 2003-12-31 | $7.6 M | 296% |
| 2002-12-31 | $1.92 M | 28.84% |
| 2001-12-31 | $1.49 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Mirati Therapeutics MRTX | $0.97 B | 3,705.28% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.29 B | 1,050.04% | 🇺🇸 USA |